Immune Checkpoint Inhibition for Hepatocellular Carcinoma, Cholangiocarcinoma, and Combined Hepatocellular-Cholangiocarcinoma is a research paper published in World Journal of Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA160688-03
Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis
National Institutes of Health
Grant: 5R01CA251545-02
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
National Institutes of Health
Grant: 5R37CA248018-04
Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies
National Institutes of Health
Grant: 5R01CA250412-02
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
FWCI
4.69
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals